Leadership Overview
ASP has 5 executives leading key functions including finance, operations, and medical strategy.
Driven by a commitment to public health, ASP manufactures essential sterilization chemicals, sanitizers, disinfectants, and dispensing equipment, impacting global hygiene standards.
Driven by a commitment to public health, ASP manufactures essential sterilization chemicals, sanitizers, disinfectants, and dispensing equipment, impacting global hygiene standards.
Leadership Roles at ASP
Vijay Kathir - Chief Financial Officer, Latin America
Vijay Kathir, the Chief Financial Officer, Latin America at ASP, directs financial operations and strategic planning across the Latin American region. Overseeing fiscal health, Kathir ensures robust financial controls and drives revenue growth initiatives tailored to market dynamics. This leadership position involves managing budgets, forecasting financial performance, and optimizing resource allocation to support ASP's sterilization and sanitization product lines. By analyzing market trends and economic conditions, Vijay Kathir guides investment decisions and mitigates financial risks, ensuring sustained profitability and operational efficiency throughout Latin America. The role demands a deep understanding of regional financial regulations and a proactive approach to capital management, directly contributing to the company's expansion and market penetration goals in diverse economic landscapes.
Harvey Lipshits - President
Harvey Lipshits, the President at ASP, spearheads the company's overall strategic direction and operational execution. This executive role involves driving innovation in sterilization chemicals, sanitizers, and dispensing equipment to meet evolving global health standards. Lipshits oversees key business units, ensuring seamless integration of manufacturing processes and supply chain logistics for disinfectants and cleaning solutions. By fostering a culture of excellence, Harvey Lipshits guides the organization toward achieving its mission of enhancing public health through advanced sterilization technologies. The leadership focus includes expanding market reach and strengthening ASP's position as a premier provider of hygiene solutions, directly impacting the company's growth trajectory and commitment to quality.
Aisha Barry - President
Aisha Barry, the President at ASP, directs critical aspects of the company's strategic growth and market development. This leadership function involves overseeing the expansion of ASP's product portfolio, including advanced cleaning chemicals, sanitizers, and disinfectants. Barry drives initiatives to enhance the manufacturing and distribution of dispensing equipment and systems, ensuring alignment with global sterilization standards. By cultivating key partnerships and exploring new market opportunities, Aisha Barry strengthens ASP's competitive advantage in the hygiene and sterilization sector. The role emphasizes operational efficiency and the successful deployment of innovative solutions, contributing significantly to the company's mission of improving public health worldwide through reliable and effective sterilization technologies.

Arun Patel - President
Arun Patel, the President at ASP, leads the company's strategic initiatives and operational oversight, focusing on the advancement of sterilization and sanitization solutions. This executive capacity involves driving the development and market introduction of new cleaning chemicals, disinfectants, and advanced dispensing equipment. Patel ensures that ASP's manufacturing operations adhere to the highest quality and safety standards, supporting the company's commitment to public health. By fostering cross-functional collaboration, Arun Patel enhances the efficiency of product delivery and customer support for sanitizers and cleaning systems. The leadership scope includes identifying emerging trends in hygiene technology and guiding the company's response to meet global demands for effective sterilization equipment.
Ivan Salgo - Chief Medical Officer & Vice President, ASP & Fortive
Ivan Salgo, the Chief Medical Officer & Vice President, ASP & Fortive at ASP, provides critical medical and scientific leadership, guiding the development and validation of sterilization and sanitization products. This role ensures that all disinfectants, cleaning chemicals, and dispensing equipment meet stringent healthcare and regulatory requirements. Salgo oversees clinical research and efficacy testing, directly influencing the product roadmap for sanitizers and hygiene solutions. By bridging medical expertise with operational strategy, Ivan Salgo champions the company's mission to enhance patient safety and public health through advanced sterilization technologies. The position involves close collaboration with R&D, manufacturing, and market access teams to ensure the clinical relevance and market acceptance of ASP's equipment and systems.
Explore Leadership Teams in Manufacturing
BD is widely perceived as a global medical technology company that develops and manufactures medical devices, diagnostic systems, laboratory equipment, and healthcare solutions. The company supports hospitals, laboratories, and healthcare providers through innovations in patient safety, drug delivery, diagnostics, and biosciences.
Company Leadership
FA
KW

Founded in 1948 and headquartered in Switzerland, Varian Medical Systems is a manufacturer of medical devices and software for the treatment of cancer and other medical conditions, utilizing radiotherapy, radiosurgery, proton therapy, and brachytherapy.
Company Leadership AS
AE
AA
InMode is a medical device manufacturing company founded in 2008 that specializes in developing and producing advanced light, laser, and radiofrequency devices for medical aesthetic applications. The company creates innovative technology for both medical practices and their patients, focusing on state-of-the-art solutions that have helped shape the medical aesthetics industry. InMode's product portfolio includes various devices designed to deliver superior results in aesthetic and medical procedures across global markets including North America, Europe, Asia Pacific, and the Middle East.
Company Leadership MM
EK


ESTABLISHMENT LABS HOLDINGS INC. (NASDAQ:ESTA) is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The Motiva Flora® tissue expander is the only regulatory-approved expander in the world with an integrated port that is MRI conditional and is used to improve outcomes in breast reconstruction following breast cancer. Mia Femtech, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 25 separate patent families worldwide and over 50 scientific studies and publications in peer-reviewed journals.
Company Leadership


